When tests showed in late 2008 that Robert Adler’s multiple myeloma needed to be treated again, his doctor prescribed the then-new anti-cancer drug Revlimid (lenalidomide). Adler was grateful he had options to treat his blood cancer. As an added bonus, this drug came in pill form, unlike the chemotherapy he had previously. Then, he got the bill.
Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Email Info@CancerTodayMag.org to sign up!